SBI JI Innovation Fund was established in June 2017 as a joint venture between SBI Holdings, a Japanese financial services group, and Vertex Israel, a prominent Israeli venture capital firm. Initially focused on bio-investments, the fund actively seeks to invest in exceptional Israeli or Israel-related venture-backed biopharma and high-tech companies across various development stages. Following the successful investment period of its initial bio fund, SBI JI is broadening its investment scope to include new sectors and geographies, fostering a bridge between Israel and Asia.